Alberico Catapano

Milan, Italy

Full Professor of Pharmacology, Director of the Center of Epidemiology and Preventive Pharmacology (SEFAP) as well as Director of the Laboratory of Lipoproteins, Immunity and Atherosclerosis at the University of Milan (Department of Pharmacological and Biomolecular

Sciences) and PhD coordinator from 2017 to 2020.
Moreover he is Director of the Center for the Study, Prevention and Therapy of Atherosclerosis of the University of Milan, at the Bassini Hospital, Head of Cardiovascular Research Line at Multimedica IRCCS Sesto San Giovanni (Mi), President of the Italian Society of Clinical and Sperimental Therapy (SITeCS) and General Director of the SISA Foundation
His main research, from 1972, interests include the study of atherosclerosis, lipids, lipoproteins and genetic dyslipidaemias, and he has made landmark observations regarding heat shock proteins and pentraxins in atherogenesis, on high-density lipoproteins in the modulation of the immune response, and on the identification of possible therapeutic targets by exploiting genetic information. Past President of the European Atherosclerosis Society (EAS), Professor Catapano is currently Co- Chairman of the EAS/European Society of Cardiology (ESC) guidelines for the treatment of dyslipoproteinaemias. Editor of Atherosclerosis Supplements, Co-editor of Atherosclerosis and Associate Editor of other scientific journals, he has authored more than 590 scientific papers in peer-reviewed journals (I.F. 10.929) and is among the highly cited scientists in 2019, 2020 and 2021 according to Clarivate

Philippe Gabriel Steg

Paris, France

– Chief, Department of Cardiology, Hôpital Bichat, Paris, France.
– Vice President for research of the board of the Assistance Publique-Hôpitaux de Paris network.
– Professor of Cardiology at Université de Paris.
– Chair of the FACT (French Alliance for cardiovascular Clinical Trials) academic research network.
Dr Steg has experience as a clinical trialist in coronary artery disease, diabetes and antithrombotics and has authored > 1 000 peer-reviewed articles. His H-Index is 116 and he has > 76 000 citations. He has been ”highly cited researcher” every year since 2014. He is Senior Associate Editor for Circulation.